Daré Bioscience Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Daré Bioscience, Inc. (DARE) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Current Assets
Cash and Cash Equivalents15.7010.4834.6751.674.674.78
Cash & Short-Term Investments15.7010.4834.6751.674.674.78
Accounts Receivable0.230.951.701.150.460.56
Inventory0.000.000.000.000.000.00
Other Current Assets2.526.122.322.481.340.94
Total Current Assets18.4517.5443.0455.306.986.44
Non-Current Assets
Property, Plant & Equipment (Net)2.541.980.520.240.040.06
Other Non-Current Assets1.100.600.250.130.530.94
Total Non-Current Assets3.653.740.790.510.571.00
Total Assets22.1021.2843.8355.817.557.44
Current Liabilities
Accounts Payable1.463.3912.922.104.383.18
Short-Term Debt0.550.000.000.000.000.00
Accrued Liabilities1.991.819.171.603.360.00
Deferred Revenue16.5613.7418.3010.541.560.00
Other Current Liabilities3.0413.701.720.001.000.00
Total Current Liabilities21.6120.4813.3216.057.663.59
Non-Current Liabilities
Long-Term Debt0.750.940.090.000.000.00
Other Non-Current Liabilities4.753.9118.300.001.613.41
Total Non-Current Liabilities6.505.8519.391.002.613.41
Total Liabilities28.1126.3332.7117.058.707.00
Stockholders' Equity
Common Stock0.000.000.010.010.000.00
Retained Earnings-175.29-171.24-141.43-110.13-71.52-44.02
Accumulated Other Comprehensive Income-0.43-0.36-0.35-0.15-0.09-0.10
Additional Paid-in Capital169.71166.55152.53149.0370.3744.56
Shares Outstanding8.708.337.077.000.000.00
Total Stockholders' Equity-6.01-5.0511.1138.75-1.150.44
Total Liabilities & Equity22.1021.2843.8355.817.557.44